Clinical studies have reported that higher levels of serum OPG is associated with poor cardiovascular outcomes in coronary artery disease, chronic kidney disease, and rheumatoid arthritis [22,23,24]. This evidence concerns the gene TNFRSF11B and coronary artery disorder.